Skip to main content
AIDX logo

AIDX · 20/20 Biolabs, Inc. · Analyst Estimates

Track AIDX — free
$0.34 -0.04 (-10.53%) At close · Oct 5
Market Cap
$5.31M
Shares
12.77M
Volume · Oct 5 119.88K Avg daily vol (3M) 92.73K

Analyst Estimates

Compare analyst forecasts for 20/20 Biolabs, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 13:05 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.42
-0.42
-0.42
—
0.0
0.0
-0.3
0.0
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
0
1
0
0
Revenue
USD
Publication date not stated
2949000
2949000
2949000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
1
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.38
-0.38
-0.38
—
0.0
0.0
-0.33
0.0
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
0
1
0
0
Revenue
USD
Publication date not stated
5772000
5772000
5772000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
1
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.06
-0.06
-0.06
—
0.0
0.0
-0.06
0.0
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
0
0
0
0
Revenue
USD
Publication date not stated
891000
891000
891000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
1
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.07
-0.07
-0.07
—
0.0
0.0
-0.06
0.0
— — — —
EPS
analysts
Publication date not stated
— — —
1
— — — —
0
1
0
0
Revenue
USD
Publication date not stated
1069000
1069000
1069000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
1
— — — — — — — —
Key facts CIK 1139685 CUSIP 90138K101 Visit website Investor relations